6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

51 trials found

diseases per page:

Showing 1 to 10 of 51 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05083260 (ClinicalTrials.gov)	January 4, 2022	23/9/2021	NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa	A Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study in Parkinson's ...	Parkinson Disease	Drug: NE3107;Drug: placebo	BioVie Inc.	NULL	Completed	30 Years	80 Years	All	46	Phase 1/Phase 2	United States
2	NCT05128175 (ClinicalTrials.gov)	October 29, 2021	27/10/2021	Comparative Bioavailability Study of Carbidopa/LevodopaExtended-Release Tablets Under Fasting and Fe ...	An Open-label, Balanced, Randomized, Five-treatment, Five-period, Five-sequence, Multiple Oral Dose, ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	18 Years	45 Years	All	15	Phase 1	India
3	NCT04380142 (ClinicalTrials.gov)	October 19, 2020	6/5/2020	Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/LevodopaTablets For ...	A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and ...	Parkinson's Disease (PD)	Drug: ABBV-951;Drug: Placebo for Levodopa /Carbidopa (LD/CD);Drug: Levodopa /Carbidopa (LD/CD);Drug: P ...	AbbVie	NULL	Completed	30 Years	N/A	All	174	Phase 3	United States;Australia
4	NCT04591535 (ClinicalTrials.gov)	September 28, 2020	11/9/2020	PK Study of WD-1603 in Healthy Subjects	An Open Label, Balanced, Randomised, Four-treatment, Four-period, Four-sequence, Single Oral Dose, C ...	Parkinson Disease	Drug: WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS	Hong Kong WD Pharmaceutical Co., Limited	NULL	Recruiting	18 Years	45 Years	All	8	Phase 1	India
5	NCT04513340 (ClinicalTrials.gov)	August 13, 2020	12/8/2020	WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects	AN OPEN LABEL, BALANCED, RANDOMISED, FOUR-TREATMENT, FOUR-PERIOD, FOUR-SEQUENCE, SINGLE INTRA-ORAL A ...	Parkinson Disease	Drug: WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS	Hong Kong WD Pharmaceutical Co., Limited	NULL	Recruiting	18 Years	45 Years	All	8	Phase 1	India
6	NCT04821830 (ClinicalTrials.gov)	February 12, 2020	10/3/2021	Vigor and the LDR in Parkinson Disease	Vigor and the LDR in Parkinson Disease	Parkinson Disease	Drug: carbidopa /levodopa, as prescribed by treating physician	University of Michigan	National Institute of Neurological Disorders and Stroke (NINDS)	Recruiting	45 Years	90 Years	All	40		United States
7	NCT03887884 (ClinicalTrials.gov)	March 5, 2019	1/3/2019	Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)	Randomized, Multi-center, Open-label, Crossover Pharmacokinetic Study of CVT-301 (Levodopa Inhalatio ...	Parkinson's Disease	Drug: CVT-301;Drug: Sinemet	Acorda Therapeutics	NULL	Completed	30 Years	85 Years	All	23	Phase 1	United States
8	EUCTR2018-001209-95-IT (EUCTR)	05/07/2018	03/08/2021	An open-label Phase 2 study to assess the pharmacokinetics of Accordion Pill¿ Carbidopa-Levodopa com ...	An open-label Phase 2 study to assess the pharmacokinetics of Accordion Pill¿ Carbidopa-Levodopa com ...	Parkinson's Disease (PD) MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson ...	Product Name: Accordion Pill¿ Carbidopa/levodopa Product Code: N.A. INN or Proposed INN: LEVODOPA Other ...	INTEC PHARMA LTD	NULL	Not Recruiting			Female: yes Male: yes	12	Phase 2	Spain;Italy
9	NCT03576638 (ClinicalTrials.gov)	July 2018	25/6/2018	Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release ...	An Open Label Phase 2 Study to Assess the Pharmacokinetics of the Accordion Pill Carbidopa-Levodopa ...	Parkinson Disease	Drug: Accordion Pill Carbidopa/Levodopa;Drug: Sinemet CR 25Mg-100Mg Extended-Release Tablet	Intec Pharma Ltd.	NULL	Unknown status	30 Years	N/A	All	12	Phase 2	NULL
10	EUCTR2015-003513-24-SK (EUCTR)	14/03/2017	04/03/2016	OPEN-LABEL EXTENSION and FOLLOW-UP of STUDY IN 11 004	An Open-Label, Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of AP-CD/LD ...	MedDRA version: 20.0;Level: HLT;Classification code 10034005;Term: Parkinson's disease and parkinso ...	Product Name: Accordion Pill™ Carbidopa/Levodopa50/400 mg INN or Proposed INN: Carbidopa Other descrip ...	Intec Pharma, Ltd.	NULL	Not Recruiting			Female: yes Male: yes	266	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Hungary;Slovakia;Poland;Spain;Ukraine;Israel;Bulgaria;Germany;Italy;United Kingdom

First Previous1 2 3 4 5 6Next Last